Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study.
Saved in:
| Title: | Implementable Deep Learning for Multi-sequence Proton MRI Lung Segmentation: A Multi-center, Multi-vendor, and Multi-disease Study. |
|---|---|
| Authors: | Astley JR; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.; Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK., Biancardi AM; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK., Hughes PJC; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK., Marshall H; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK., Collier GJ; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK., Chan HF; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK., Saunders LC; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK., Smith LJ; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK., Brook ML; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK., Thompson R; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Rowland-Jones S; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Skeoch S; Royal National Hospital for Rheumatic Diseases, Royal United Hospital NHS Foundation Trust, Bath, UK.; Arthritis Research UK Centre for Epidemiology, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester, UK., Bianchi SM; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Hatton MQ; Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK., Rahman NM; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UK., Ho LP; MRC Human Immunology Unit, University of Oxford, Oxford, UK., Brightling CE; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Wain LV; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.; Department of Health sciences, University of Leicester, Leicester, UK., Singapuri A; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK., Evans RA; University Hospitals of Leicester NHS Trust, University of Leicester, Leicester, UK., Moss AJ; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., McCann GP; The Institute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.; Department of Cardiovascular Sciences, University of Leicester, Leicester, UK., Neubauer S; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UK., Raman B; Division of Cardiovascular Medicine, Radcliffe Department of Medicine, National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), University of Oxford, Oxford, UK., Wild JM; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.; Insigneo Institute for In Silico Medicine, The University of Sheffield, Sheffield, UK., Tahir BA; POLARIS, Department of Infection, Immunity & Cardiovascular Disease, The University of Sheffield, Sheffield, UK.; Department of Oncology and Metabolism, The University of Sheffield, Sheffield, UK.; Insigneo Institute for In Silico Medicine, The University of Sheffield, Sheffield, UK. |
| Corporate Authors: | C-MORE/PHOSP-COVID Collaborative Group |
| Source: | Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2023 Oct; Vol. 58 (4), pp. 1030-1044. Date of Electronic Publication: 2023 Feb 17. |
| Publication Type: | Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 9105850 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1522-2586 (Electronic) Linking ISSN: 10531807 NLM ISO Abbreviation: J Magn Reson Imaging Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1522-2586 |
|---|---|
| DOI: | 10.1002/jmri.28643 |
